newsfilter
← Latest News
GlobeNewswire·

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial